Author: David Hagebush Melanoma tissue on frozen section with H&E staining and MART-1 staining. In an important article Melanoma Treated With Mohs Micrographic Surgery Using a Novel-Modified 15-Minute Mart-1 Immunostain: Discussion of Technique and Experience published in Dermatologic Surgery, a group of clinicians from Minnesota were the first to report their success adapting and utilizing […]
As the Coronavirus outbreak continues, Novodiax is committed to flattening the curve while serving customers. Please be safe during this time and know we will continue to provide the products on which our customers and their patients depend. We will be using a combination of videoconferencing and test samples as substitutes for in person meetings […]
Novodiax research scientist Shuo Chen, PhD recently presented a poster on rapid immunocytochemistry (ICC) at the 109th annual United States and Canadian Association of Pathology (USCAP) meeting in Los Angeles. This presentation was the culmination of a year-long investigation into the use of Novodiax polyHRP-conjugated antibodies (ihcDirect®) for novel applications in rapid immunocytochemistry (ICC). There’s […]
Breast cancer is the most common cancer in women worldwide, and there is a serious need for innovative approaches to its diagnosis and treatment. In a clinical study performed at the PLA General Hospital, Novodiax ihcDirect® Cytokeratin 5 (CK5) and SMMS-1 (SMMHC) rapid 10-minute IHC tests were shown to improve intra-operative assessment of breast lesions, resulting in…
HAYWARD, CA—Novodiax, a pioneering developer of rapid immunoassays, today announced the launch of the new ihc Magenta 1:1 chromogen for immunohistochemistry (IHC) testing. This product is intended for use with horseradish peroxidase (HRP) based IHC and other immunoassays, where it produces a striking reddish-purple color at the site of antibody-antigen interaction. “With the introduction of […]
From leading the development of Novodiax’s polyHRP platform technology and rapid immunohistochemistry assays to designing instruments and tools that help improve immunoassay test workflows (e.g. ihc Slide Manager), Jin Wu, PhD has been an instrumental part of the Novodiax team dedicated to delivering cutting-edge, high quality products for our customers. For this first installment of […]
Press Release Novodiax launches ihcDirect® CD20 and ihcDirect Vimentin antibody assays. Hayward, CA, December 16, 2018– Novodiax Inc., a leader in intraoperative immunohistochemistry (IHC) technology, announces the availability of two new ihcDirect staining kits for in vitro diagnostic (IVD) use: CD20 and Vimentin. “These two new products demonstrate our commitment to deliver rapid 10-minute IHC […]
Press Release Novodiax introduces ihcDirect® Pan-CK 4Abs, AE1/AE3, CEA, and CD45 reagents to growing list of 10-Minute IHC Assays for in-vitro diagnostic use. Hayward, CA, August 16, 2018– Novodiax Inc., a leader in intraoperative immunohistochemistry (IHC) technology, announces the availability of four new ihcDirect staining kits for in vitro diagnostic (IVD) use: Pan-CK […]
Novodiax receives two awards for Innovative in-vitro Diagnostic Tests for Cancer. Check out our latest press release below! Novodiax Receives Two Awards- Press Release
Ruth prepping for a demo in a conference room. No problem!
- 1
- 2